King Rachel K.
Insider CIK 1589712 · NVAX Director · GLYC President, CEO, Director · FULC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 32,000 | — | $0 | 32,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 44,070 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 21,270 | — | $0 | 21,270 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,180 | — | $0 | 14,180 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 36,000 | — | $0 | 36,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 18,884 | — | $0 | 18,884 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 28,326 | $6.42 | $181.9K | 28,326 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 25,190 | SEC↗ |
| NVAX NOVAVAX INC | S Sale | 2024-12-13 | 2025-01-02 | 4,150 | $9.02 | $37.4K | 14,770 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-11-12 | 2024-11-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 10,420 | — | $0 | 10,420 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 15,630 | $15.86 | $247.9K | 15,630 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 18,920 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2024-05-01 | 2024-05-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2024-03-29 | 2024-04-02 | 3,334 | $3.00 | $10.0K | 515,194 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2023-12-29 | 2024-01-02 | 4,238 | $2.36 | $10.0K | 511,860 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2023-09-30 | 2023-10-03 | 6,667 | $1.50 | $10.0K | 507,622 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 6,670 | — | $0 | 6,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 7,710 | — | $0 | 7,710 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 10,050 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2023-05-19 | 2023-05-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 6,950 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 4,600 | — | $0 | 4,600 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 3,100 | — | $0 | 3,100 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2022-05-18 | 2022-05-20 | 21,000 | — | $0 | 21,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-06-25 | 2021-08-20 | 3,450 | — | $0 | 3,450 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-06-25 | 2021-08-20 | 3,450 | — | $0 | 6,250 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-06-25 | 2021-06-29 | 6,900 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-06-25 | 2021-06-29 | 6,900 | — | $0 | 9,700 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 700 | — | $0 | 700 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2021-05-19 | 2021-05-21 | 700 | $139.64 | $97.7K | 2,800 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2021-01-20 | 2021-01-22 | 192,500 | — | $0 | 192,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2021-01-20 | 2021-01-22 | 96,250 | — | $0 | 452,314 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise deriv | 2020-12-28 | 2020-12-30 | 130,821 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise | 2020-12-28 | 2020-12-30 | 130,821 | $1.12 | $146.5K | 440,240 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2020-12-28 | 2020-12-30 | 84,176 | $3.91 | $329.1K | 356,064 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-26 | 3,450 | — | $0 | 3,450 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-26 | 6,900 | — | $0 | 6,900 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2020-01-22 | 2020-01-24 | 349,000 | — | $0 | 349,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-12-12 | 2019-12-16 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise deriv | 2019-08-06 | 2019-08-07 | 166,759 | — | $0 | 130,821 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise | 2019-08-06 | 2019-08-07 | 166,759 | $1.12 | $186.8K | 307,144 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2019-03-27 | 2019-03-28 | 22,000 | $0.53 | $11.7K | 22,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2019-03-27 | 2019-03-28 | 22,000 | $0.53 | $11.7K | 22,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2019-03-27 | 2019-03-28 | 42,000 | $0.53 | $22.3K | 42,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2019-01-17 | 2019-01-22 | 265,000 | — | $0 | 265,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2018-10-31 | 2018-11-02 | 160,000 | — | $0 | 160,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-01-10 | 2018-01-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2017-01-04 | 2017-01-05 | 175,000 | — | $0 | 175,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-01-07 | 2016-01-11 | 141,000 | — | $0 | 141,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise deriv | 2015-02-24 | 2015-02-26 | 50,000 | — | $0 | 297,580 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise | 2015-02-24 | 2015-02-26 | 50,000 | $1.12 | $56.0K | 167,206 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2015-01-08 | 2015-01-12 | 141,000 | — | $0 | 141,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise deriv | 2014-06-18 | 2014-06-20 | 100,000 | — | $0 | 347,580 | SEC↗ |
| GLYC GLYCOMIMETICS INC | M Exercise | 2014-06-18 | 2014-06-20 | 100,000 | $1.12 | $112.0K | 108,706 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2014-01-09 | 2014-01-13 | 375,639 | — | $0 | 375,639 | SEC↗ |